NYSE:MCKHealthcare
McKesson (NYSE:MCK) Reports US$90 Billion Sales With 66% Q4 Net Income Rise
McKesson (NYSE:MCK) recently reported a significant increase in earnings for the fourth quarter and full year, reflecting robust growth in sales and net income. This performance, alongside the launch of its Precision Care Companion initiative in April, highlights the company's strategic focus on improving healthcare outcomes. Simultaneously, McKesson's declared dividend and the strong financial results likely bolstered investor confidence, aligning with a broader market trend of 1.3% growth...